|
|||||
|
|
Comparative treatment-related adverse event cost burden in immune thrombocytopenic purpura |
|
| Authors: | Prina Z. Donga Gregg Little Tim Babinchak Julie Munakata |
| Affiliation: | 1. IMS Health, Plymouth Meeting, PA, USA;2. Emergent BioSolutions, Gaithersberg, MD, USA;3. IMS Health, San Francisco, CA, USA |
| Abstract: | |
| Keywords: | ITP immune thrombocytopenia purpura cost adverse event claims analysis |